Analyst Scoreboard: 4 Ratings For Healthcare Realty Trust
Portfolio Pulse from Benzinga Insights
Analysts have recently updated their ratings and price targets for Healthcare Realty Trust (NYSE:HR), showing a shift towards a more cautious outlook. Over the last three months, 4 analysts have provided ratings, with the latest consensus indicating 1 somewhat bullish and 3 indifferent stances. The average 12-month price target has been adjusted to $16.25, down from $19.00, reflecting a 14.47% decrease. This change is based on market conditions and company performance, including a -2.25% revenue decline and below-average profitability metrics such as net margin and ROE.
March 06, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Healthcare Realty Trust has seen a downward revision in analyst ratings and price targets, reflecting concerns over its financial performance, including a revenue decline and lower profitability metrics.
The adjustment in analyst ratings and price targets for HR is a direct response to its recent financial performance, including a notable revenue decline and challenges in maintaining profitability. These factors are critical for investors, as they impact the company's growth prospects and financial health, potentially leading to a decrease in stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100